<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="2209">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on October 07, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04360837</url>
  </required_header>
  <id_info>
    <org_study_id>COVID-19EIT</org_study_id>
    <nct_id>NCT04360837</nct_id>
  </id_info>
  <brief_title>PEEP Incremental and Decremental Alveolar Recruitment of Critically Ill Corona Virus Disease-19 (COVID-19) Patients</brief_title>
  <official_title>PEEP Incremental and Decremental Alveolar Recruitment of Critically Ill COVID-19 Patients Under Electric Impedance Tomography (EIT)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Szeged University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Furtwangen University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>BUDAPEST UNIVERSITY OF TECHNOLOGY AND ECONOMICS</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Szeged University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      COVID-19 originated from Severe Acut Respiratory Syndrome Coronavirus-2 (SARS-CoV-2)
      infection leads to critical condition due to hypoxemic respiratory failure with the
      background of viral pneumonia. Both alevolar recruitment and the subsequent optimal positive
      end-expiratory pressure (PEEP) adjustment has a pivotal role in the elimination of
      atelectasis developed by inflammation in the lung parenchyma The gold standard of the follow
      up of recruitment manoeuvre is the chest computed tomography (CT) examination. However,
      reduction of intrahospital transport and the exposure with healthcare workers are recommended
      because of the extremely virulent pathogen spreading easily by droplet infection. In this
      case bedside investigations have an utmost importance in the management of hygiene
      regulations.

      Electric impedance tomography (EIT) is a non-invasive, radiation free functional imaging
      technique easily applicable at the bedside.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      COVID-19 originated from Severe Acut Respiratory Syndrome Coronavirus-2 (SARS-CoV-2)
      infection leads to critical condition in 5% of the cases due to hypoxemic respiratory failure
      with the background of viral pneumonia. 90% of these patients require invasive mechanical
      ventilation on critical care units. Both alevolar recruitment and the subsequent optimal
      positive end-expiratory pressure (PEEP) adjustment has a pivotal role in the eliminitaion of
      atelectasis developed by inflammation in the lung parenchyma.

      The gold standard of the follow up of recruitment manoeuvre is the chest computed tomography
      (CT) examination. However, reduction of intrahospital transport and the exposure with
      healthcare workers are recommended because of the extremely virulent pathogen spreading
      easily by droplet infection. In this case bedside investigations have an utmost importance in
      the management of hygiene regulations.

      Electric impedance tomography (EIT) is a non-invasive, radiation free functional imaging
      technique easily applicable at the bedside. With the help of EIT, intrathoracic impedance
      changes, resulting from air and blood volume variations, can be determined by
      circumferentially attached surface electrodes around the thorax, applying small alternating
      currents and measuring differences in surface potentials. The calculated difference in
      potential is utilised to reconstruct impedance images what is employed to assess ventilation
      and perfusion distribution. Several local and global variances can be estimated just like the
      ratio fo atelectatic/overdistended alveoli, the ratio of aeration in the anterior/posterior
      regions, the inhomogeneity of aeration or regional compliance.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 6, 2020</start_date>
  <completion_date type="Anticipated">June 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">June 1, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Changes in lung compliance</measure>
    <time_frame>20 minutes</time_frame>
    <description>Estimation of change in compliance (ml/cmH2O) from the beginning to end of of the incremental/decremental PEEP alveolar recruitment.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in global impedance</measure>
    <time_frame>20 minutes</time_frame>
    <description>Estimation of change in global impedance (%) from the beginning to end of of the incremental/decremental PEEP alveolar recruitment.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in recruitability</measure>
    <time_frame>7 days</time_frame>
    <description>Estimation of change in global impedance (%) on a daily manner.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Gas exchange</measure>
    <time_frame>20 minutes and 7 days</time_frame>
    <description>Change in arterial partial pressure of oxygen (PaO2) (mmHg) following recruitment</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Plateau pressure</measure>
    <time_frame>20 minutes and 7 days</time_frame>
    <description>Change in plateau pressure (cmH2O) following recruitment</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>End expiratory lung impedance (EELI)</measure>
    <time_frame>20 minutes and 7 days</time_frame>
    <description>Change in end expiratory lung impedance (%)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Antero-to-posterior ventilation ratio</measure>
    <time_frame>20 minutes and 7 days</time_frame>
    <description>Change in antero-to-posterior ventilation ratio (%) following intervention</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Center of ventilation</measure>
    <time_frame>20 minutes and 7 days</time_frame>
    <description>Change in center of ventilation (%) following intervention</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Global inhomogeneity index</measure>
    <time_frame>20 minutes and 7 days</time_frame>
    <description>Change in global inhomogeneity index (%) following intervention</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">10</enrollment>
  <condition>COVID-19</condition>
  <condition>Virus; Pneumonia</condition>
  <condition>Atelectasis</condition>
  <arm_group>
    <arm_group_label>PEEP incremental-decremental alveolar recruitment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>installing EIT belt over the chest at the level of the 5th intercostal space and adjustment of the default recruitment settings in pressure control ventilation mode: pressure control 15 cmH20, PEEP 10 cmH2O, fraction of inspired oxygen (FiO2) and respiratory rate according to the discretion of the attending physician, recording basal parameters
implementation of recruitment:
increment phase: increasing PEEP by 3 cmH2O in every two minutes from 10 cmH2O until top of PEEP 25 cmH2O
decrement phase: decreasing PEEP by 3 cmH20 in every two minutes from 25 cmH20 until the basal PEEP 10 cmH20
end inspiratory hold manoeuvre at every PEEP level
recording closing parameters
Repeating the above detailed intervention once daily as long as the patient is controlled ventilation.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>alveolar recruitment</intervention_name>
    <description>incremental and decremental positive end-expiratory pressure alveolar recruitment</description>
    <arm_group_label>PEEP incremental-decremental alveolar recruitment</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  SARS-CoV-2 positivity confirmed by polymerase chain reaction

          -  orotracheally intubated patients

          -  pressure control ventilation mode

          -  sedation level of minimum -4 on the Richmond Agitation Sedation Scale (RASS)

        Exclusion Criteria:

          -  age under 18

          -  pregnancy

          -  pulmonectomy, lung resection in the past medical history

          -  clinically end stage chronic obstructive pulmonary disease

          -  sever hemodynamic instability (vasopressor refractory shock)

          -  sever bullous emphysema and/or spontaneous pneumothorax in the past medical history
             chest drainage in situ due to pneumothorax and/or bronchopleural fistula
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>99 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>András Lovas, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>SZTE AITI</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>András Lovas, MD PhD</last_name>
    <phone>003662545168</phone>
    <email>lovas.andras@med.u-szeged.hu</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of Szeged</name>
      <address>
        <city>Szeged</city>
        <zip>6725</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>András Lovas, MD</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Hungary</country>
  </location_countries>
  <reference>
    <citation>Gattinoni L, Caironi P, Cressoni M, Chiumello D, Ranieri VM, Quintel M, Russo S, Patroniti N, Cornejo R, Bugedo G. Lung recruitment in patients with the acute respiratory distress syndrome. N Engl J Med. 2006 Apr 27;354(17):1775-86.</citation>
    <PMID>16641394</PMID>
  </reference>
  <reference>
    <citation>Frerichs I, Amato MB, van Kaam AH, Tingay DG, Zhao Z, Grychtol B, Bodenstein M, Gagnon H, Böhm SH, Teschner E, Stenqvist O, Mauri T, Torsani V, Camporota L, Schibler A, Wolf GK, Gommers D, Leonhardt S, Adler A; TREND study group. Chest electrical impedance tomography examination, data analysis, terminology, clinical use and recommendations: consensus statement of the TRanslational EIT developmeNt stuDy group. Thorax. 2017 Jan;72(1):83-93. doi: 10.1136/thoraxjnl-2016-208357. Epub 2016 Sep 5.</citation>
    <PMID>27596161</PMID>
  </reference>
  <reference>
    <citation>Lovas A, Hankovszky P, Korsós A, Kupcsulik S, Molnár T, Szabó Z, Babik B. Importance of the imaging techniques in the management of COVID-19-infected patients. Orv Hetil. 2020 Apr 1;161(17):672-677. doi: 10.1556/650.2020.31814. Review. Hungarian.</citation>
    <PMID>32324360</PMID>
  </reference>
  <results_reference>
    <citation>Grasselli G, Zangrillo A, Zanella A, Antonelli M, Cabrini L, Castelli A, Cereda D, Coluccello A, Foti G, Fumagalli R, Iotti G, Latronico N, Lorini L, Merler S, Natalini G, Piatti A, Ranieri MV, Scandroglio AM, Storti E, Cecconi M, Pesenti A; COVID-19 Lombardy ICU Network. Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy. JAMA. 2020 Apr 28;323(16):1574-1581. doi: 10.1001/jama.2020.5394.</citation>
    <PMID>32250385</PMID>
  </results_reference>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>April 22, 2020</study_first_submitted>
  <study_first_submitted_qc>April 22, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">April 24, 2020</study_first_posted>
  <last_update_submitted>May 19, 2020</last_update_submitted>
  <last_update_submitted_qc>May 19, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 21, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Szeged University</investigator_affiliation>
    <investigator_full_name>András Lovas</investigator_full_name>
    <investigator_title>consultatnt in critical care and anaesthesiology</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pneumonia, Viral</mesh_term>
    <mesh_term>Pneumonia</mesh_term>
    <mesh_term>Pulmonary Atelectasis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

